Francine Kauffmann, MD, Florence Demenais, MD 

Slides:



Advertisements
Similar presentations
D-dimer: A biomarker for antihistamine-resistant chronic urticaria
Advertisements

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
Stephen Joseph Galli, MD  Journal of Allergy and Clinical Immunology 
Risks for infection in patients with asthma (or other atopic conditions): Is asthma more than a chronic airway disease?  Young J. Juhn, MD, MPH  Journal.
Doina M. Racila, MD, Joel N. Kline, MD, MSc 
Pharmacologic rationale for treating allergic and nonallergic rhinitis
Asthma exacerbations: Origin, effect, and prevention
Kyoung-Bok Min, MD, PhD, Jin-Young Min, PhD 
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Ann-Marie M. Schoos, MD, PhD, Jacob D
Advances in pediatric asthma in 2011: Moving forward
Klaus Bønnelykke, MD, PhD, Carole Ober, PhD 
Atopic dermatitis: Age and race do matter!
Disparities in allergic disease: Hypersensitivity and social disorders
David A. Khan, MD  Journal of Allergy and Clinical Immunology 
Is 9 more than 2 also in allergic airway inflammation?
Desensitization to Chemotherapeutic Agents
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
Rising prevalence of asthma is sex-specific in a US farming population
Changing trends and challenges in the management of asthma in Asia
Advancing asthma care: The glass is only half full!
Functional FCGR2B gene variants influence intravenous immunoglobulin response in patients with Kawasaki disease  Sadeep Shrestha, PhD, Howard W. Wiener,
Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J
The National Biome Initiative: An allergy perspective
A network-based analysis of the late-phase reaction of the skin
Peter M. Wolfgram, MD, David B. Allen, MD 
Update on epigenetics in allergic disease
Asthma treatment and asthma prevention: A tale of 2 parallel pathways
Successful management of mite-allergic asthma with modified extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae in a double-blind,
Jewlya Lynn, PhD, Sophie Oppenheimer, MS, MPH, Lorena Zimmer, MA 
Reply Journal of Allergy and Clinical Immunology
Phillip Lieberman, MD, Michael Tankersley, MD 
Environmental determinants of allergy and asthma in early life
Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation  Leif Bjermer, MD  Journal of Allergy.
What are the best outcome measurements for atopic eczema
Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management  Scott H. Sicherer, MD, Hugh A. Sampson, MD  Journal.
Biosimilars and drug development in allergic and immunologic diseases
Daphne Koinis-Mitchell, PhD, Timothy Craig, DO, Cynthia A
Effect of ingested H1 antihistamines on methacholine challenge
What is an “eosinophilic phenotype” of asthma?
Weiguo Chen, PhD, Gurjit K. Khurana Hershey, MD, PhD 
H. William Kelly, PharmD  Journal of Allergy and Clinical Immunology 
Personalized asthma therapy in blacks—the role of genetic ancestry
Cockroach allergens: Coping with challenging complexity
Autophagy: Nobel Prize 2016 and allergy and asthma research
Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment
Advances in the approach to the patient with food allergy
Diagnosis and management of early asthma in preschool-aged children
Prevention of food allergy: Beyond peanut
The impact of a history of asthma on long-term outcomes of people with newly diagnosed chronic obstructive pulmonary disease: A population study  Tetyana.
Risk of oral food challenges
The National Institutes of Allergy and Infectious Diseases networks on asthma in inner- city children: An approach to improved care  William W. Busse,
Thomas Gensollen, PhD, Richard S. Blumberg, MD 
Pathophysiology of asthma: What has our current understanding taught us about new therapeutic approaches?  Stephen T. Holgate, MD, FMedSci  Journal of.
New approaches to personalized medicine for asthma: Where are we?
Endotoxin and the lung: Insight into the host-environment interaction
Measles and immunomodulation
Early-life environmental exposures interact with genetic susceptibility variants in pediatric patients with eosinophilic esophagitis  Elizabeth T. Jensen,
The Editors' Choice Journal of Allergy and Clinical Immunology
Harald Renz, MD, Ingo B. Autenrieth, MD, Per Brandtzæg, PhD, William O
Macrolide antibiotics and asthma treatment
Vitamin D in allergic disease: Shedding light on a complex problem
Frederikke K. Lomholt, BMSc, Sune F. Nielsen, PhD, Børge G
Asthma: The past, future, environment, and costs
Genetic regulation of IgE responses: Achilles and the tortoise
Environmental factors and eosinophilic esophagitis
Advances in pediatric asthma in 2007
Natural history of cow’s milk allergy
Primary prevention of asthma and allergy
Epigenetic mechanisms and the development of asthma
Presentation transcript:

Gene-environment interactions in asthma and allergic diseases: Challenges and perspectives  Francine Kauffmann, MD, Florence Demenais, MD  Journal of Allergy and Clinical Immunology  Volume 130, Issue 6, Pages 1229-1240 (December 2012) DOI: 10.1016/j.jaci.2012.10.038 Copyright © 2012 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 Paradigms. A, The point of view of philosophers of science (from Descartes R, Discours de la méthode, 16374). B, The point of view of genetics-oriented specialists (modified from Schork5). C, The point of view of environment-oriented specialists (after Schulte7). Journal of Allergy and Clinical Immunology 2012 130, 1229-1240DOI: (10.1016/j.jaci.2012.10.038) Copyright © 2012 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 Models of GxE interaction and examples in the area of asthma. The left panel presents theoretical models of the effects of high-risk genotype and environmental exposure on disease (modified from Ottman16). The right panel presents 2 situations taken from the asthma literature in which only the second (flip-flop) is independent of the scale of measurement (modified from Ober and Vercelli17). Journal of Allergy and Clinical Immunology 2012 130, 1229-1240DOI: (10.1016/j.jaci.2012.10.038) Copyright © 2012 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 3 GxE interactions: a complex challenge including time. The time axis represents the individual life course, with changes in environment corresponding to cohort effects (black and light gray lines). Within their life course, some subjects can experience cohort-like acute changes in case of migration or cohort-like subacute changes in epidemiologic transitional situations occurring in developing countries. Such changes can result in new combinations of exposures at a given time or over the life course. Time is of particular importance in the context of the Developmental Origins of Health (DoHad) hypothesis.76 Disappearance of protective factors (eg, modification of the microbiome) and emergence of new deleterious factors (eg, new occupational cleaning agents) are cohort related and influence the windows of expression of asthma. Gene effect on disease can also vary with time, either at the individual level (regulation of gene expression) or at the population level (selection and evolution). The concept of the exposome42 aims at integrating multiple exposures over the lifespan. Finally, phenotypes will result in the interactions of gene networks, in which homeostasis will have a regulatory effect, with potential infinite interaction events with various elements of the exposome. Although ambitious approaches to address various aspects simultaneously are emerging, the challenge remains formidable and, as described by Descartes,4 it is necessary to combine realistic research strategies to disentangle the puzzle. Journal of Allergy and Clinical Immunology 2012 130, 1229-1240DOI: (10.1016/j.jaci.2012.10.038) Copyright © 2012 American Academy of Allergy, Asthma & Immunology Terms and Conditions